Patent ID: 9320767
Filing Date: 2016-04-26
CPC Classification: A23K,A23L,A23P,A23V,A23Y,A61K,A61Q,Y02A

Claim Text:
1. A method for the treatment of disorders related to a compromised immune defense, the method comprising administering to an individual in need of same a composition comprising non-replicating probiotic micro-organisms selected from the group consisting of Bifidobacterium longum NCC 3001, Bifidobacterium longum NCC 2705, Bifidobacterium breve NCC 2950, Bifidobacterium lactis NCC 2818, Lactobacillus johnsonii NCC533, Lactobacillus paracasei NCC 2461, Lactobacillus rhamnosus NCC 4007, Lactobacillus reuteri DSM17938, Lactobacillus reuteri ATCC55730, Streptococcus thermophilus NCC 2019, Streptococcus thermophilus NCC 2059, Lactobacillus casei NCC 4006, Lactobacillus acidophilus NCC 3009, Lactobacillus casei ACA-DC 6002 (NCC 1825), Escherichia coli Nissle, Lactobacillus bulgaricus NCC 15, Lactococcus lactis NCC 2287, and combinations thereof, wherein the probiotic micro-organisms are rendered non-replicating by direct expansion extrusion cooking at a temperature between 110 and 180° C. and at a moisture content below 20 wt %, and wherein the non-replicating probiotic micro-organisms comprise between 10 5 and 10 9 cfu/g of the composition.